Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines
Anthony Myint, Myron J. Tong, Simon W. Beaven – 7 May 2020
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
Francesco Violi, Annarita Vestri, Danilo Menichelli, Arianna Di Rocco, Daniele Pastori, Pasquale Pignatelli – 7 May 2020 – Direct oral anticoagulants (DOACs) have had a positive impact in preventing cardioembolic stroke in patients with atrial fibrillation (AF) who were associated with lower bleeding complications; however, data on subjects with concomitant advanced liver diseases (ALDs) are poor. This meta‐analysis evaluates bleeding and thromboembolic complications in patients with coexisting AF and ALD who were treated with DOACs or vitamin K antagonists (VKAs).
TMEM9‐v‐ATPase Activates Wnt/β‐Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis
Youn‐Sang Jung, Sabrina A. Stratton, Sung Ho Lee, Moon‐Jong Kim, Sohee Jun, Jie Zhang, Biyun Zheng, Christopher L. Cervantes, Jong‐Ho Cha, Michelle C. Barton, Jae‐Il Park – 7 May 2020
EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
Massimo Colombo – 7 May 2020
Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention
Evelyn F. Miller – 7 May 2020
Isolated Elevated Bilirubin
Hersh Shroff, Haripriya Maddur – 7 May 2020
REPLY
Liang Li, Yanpin Wei, Hongyang Wang – 6 May 2020
Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs
Salvatore Gruttadauria, the Italian Board of Experts in Liver Transplantation (I‐BELT) Study Group, The Italian Society of Organ Transplantation (SITO) – 6 May 2020
Liver Transplant Survivorship
Jennifer C. Lai, Nneka N. Ufere, John C. Bucuvalas – 6 May 2020 – For both children and adults with end‐stage liver disease, liver transplantation represents a lifelong treatment, not a cure. The physical and psychological process of undergoing transplantation begins well before the surgery itself. Concerns regarding suffering and death from end‐stage liver disease are replaced by a lifelong need for multiple medications, ongoing monitoring of graft function, and heightened vigilance for complications related not only to the transplant itself but to longterm immunosuppression.